Prestwick Chemical is open to join or form consortia, especially for the next FP7 call in September 2012.
Prestwick Chemical a premium provider of drug discovery services was founded in 1999 by Prof. C. G. Wermuth, a world-known expert in medicinal chemistry, along with top scientists from Strasbourg University.
Prestwick Chemical, located in the Strasbourg Innovation Park, offers a broad range of integrated drug discovery services, with a focus/expertise in all areas of medicinal chemistry, ranging from custom synthesis (including patent exemplification), to research projects aimed at hit validation, ligand profiling, and lead optimization.
Prestwick’s experienced team of intuitive medicinal chemists develops innovative medicinal chemistry strategies tailored to the client’s needs. They are supported by state of the art computer-aided molecular design, large-scale virtual screening, state of the art organic chemistry labs, and expertise to address ADME/TOX and selectivity issues. In addition to research services, Prestwick Chemical provides the pharmaceutical…
View original post 141 more words